Business
People of color shouldn’t be treated equally in COVID-19 vaccine trials, ER doctor says: They should be over-represented – MarketWatch
Ensuring that there’s a diverse group of participants is ‘a bottom line issue’ for investors, the emergency room physician says
This interview is part of a series of conversations MarketWatch is conducting with some of the leading voices in the U.S. on the COVID-19 pandemic.Dr. Esther Choo, an emergency room physician who studies racism and sexism in medicine, says there should be a disproportionate representation of people of color in the COVID-19 vaccine studies. BioNTech SE
BNTX,
+4.10%
,
Moderna Inc.
MRNA,
-2.17%
,
and Pfizer Inc.
PFE,
+3.83%
have publicly said theyre pushing to enroll a more di…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General11 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals